Two Sigma Investments’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,141
| Closed | -$33.5K | – | 3164 |
|
|
2024
Q3 | $33.5K | Buy |
+34,141
| New | +$33.5K | ﹤0.01% | 2923 |
|
|
2024
Q2 | – | Sell |
-40,602
| Closed | -$92.2K | – | 2970 |
|
|
2024
Q1 | $92.2K | Buy |
40,602
+15,209
| +60% | +$34.5K | ﹤0.01% | 2764 |
|
|
2023
Q4 | $74.4K | Buy |
+25,393
| New | +$74.4K | ﹤0.01% | 2880 |
|
|
2022
Q1 | – | Sell |
-24,974
| Closed | -$407K | – | 2607 |
|
|
2021
Q4 | $407K | Sell |
24,974
-113,696
| -82% | -$1.85M | ﹤0.01% | 2064 |
|
|
2021
Q3 | $2.2M | Sell |
138,670
-18,859
| -12% | -$299K | ﹤0.01% | 1306 |
|
|
2021
Q2 | $14.6M | Sell |
157,529
-3,362
| -2% | -$311K | 0.03% | 523 |
|
|
2021
Q1 | $8.37M | Buy |
160,891
+131,183
| +442% | +$6.82M | 0.02% | 640 |
|
|
2020
Q4 | $802K | Buy |
29,708
+7,849
| +36% | +$212K | ﹤0.01% | 1427 |
|
|
2020
Q3 | $612K | Buy |
21,859
+20,282
| +1,286% | +$568K | ﹤0.01% | 1340 |
|
|
2020
Q2 | $23K | Buy |
1,577
+245
| +18% | +$3.57K | ﹤0.01% | 1922 |
|
|
2020
Q1 | $15K | Sell |
1,332
-2,035
| -60% | -$22.9K | ﹤0.01% | 1828 |
|
|
2019
Q4 | $70K | Buy |
+3,367
| New | +$70K | ﹤0.01% | 2071 |
|
|
2019
Q1 | – | Sell |
-1,212
| Closed | -$34K | – | 2130 |
|
|
2018
Q4 | $34K | Buy |
+1,212
| New | +$34K | ﹤0.01% | 2018 |
|
|
2018
Q3 | – | Sell |
-1,985
| Closed | -$77K | – | 2029 |
|
|
2018
Q2 | $77K | Buy |
+1,985
| New | +$77K | ﹤0.01% | 1953 |
|
|
2015
Q3 | – | Sell |
-1,644
| Closed | -$93K | – | 1688 |
|
|
2015
Q2 | $93K | Buy |
+1,644
| New | +$93K | ﹤0.01% | 2098 |
|